R&D Systems™ Recombinant Human IL-29/IFN-lambda 1 Protein

E. coli-expressed

Brand:  R&D Systems™ 11240-IL-050

Product Code. 18757786

Description

Measured in an anti-viral assay using HepG2 human hepatocellular carcinoma cells infected with encephalomyocarditis (EMC) virus. Sheppard, P. et al. (2003) Nat. Immunol. 4:63. The ED50 for this effect is 0.500-6.00 ng/mL.

Specifications

• Accession Number: Q8IU54.1
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Molecular Weight (g/mol): M.W. Observed: 18-22 kDa, under reducing conditions., M.W. Theoretical: 20 kDa
• Source: E. coli-derived human IL-29/IFN-lambda 1 protein Pro23-Thr200
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

• For Use With (Application): Bioactivity
• Gene ID (Entrez): 282618
• Quantity: 50 μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
• Gene Alias: cytokine Zcyto21, IFNL1, IFN-lambda 1, IFN-lambda-1, IL29, IL-29, interferon lambda-1, interferon, lambda 1, interleukin 29 (interferon, lambda 1), interleukin-29, ZCYTO21
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Protein: IL-29/IFN-lambda 1